Related scientific articles (all)

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

Authors : Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, DHaens G, Paesmans M, Peeters M, Efira A, Humblet Y
Year : 2012
Journal : Acta Gastroenterol Belg
Volume : 75(1)
Pages : 14-21

Non-HIV Kaposi's sarcoma: a review and therapeutic perspectives.

Authors : Akasbi Y, Awada A, Arifi S, Mellas N, El Mesbahi O
Year : 2012
Journal : Bull Cancer
Volume : 99(10)
Pages : 92-9

Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer.

Authors : Farhat FS, Tfayli A, Fakhruddin N, Mahfouz R, Otrock ZK, Alameddine RS, Awada A, Shamseddine A
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 84(2)
Pages : 149-60

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors : Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, Mcgale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart-Gebhart M, Pritchard K
Year : 2012
Journal : Lancet
Volume : 379(9814)
Pages : 432-44

Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.

Authors : Fernández-Cuesta L, Oakman C, Falagan-Lotsch P, Smoth KS, Quinaux E, Buyse M, Dolci MS, de Azambuja E, Hainaut P, + collaborators (among others :, Larsimont D, Piccart-Gebhart M, Olivier M
Year : 2012
Journal : Breast Cancer Res
Volume : 14(3)
Pages : R70

EORTC 24051: Unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinoma.

Authors : Lalami Y, Specenier PM, Awada A, Lacombe D, Liberatoscioli C, Fortpied C, El-Hariry I, Bogaerts J, Andry G, Langendijk HJ, Vermorken JB
Year : 2012
Journal : Radiother Oncol
Volume : 105(2)
Pages : 238-40

Chemoprevention for breast cancer.

Authors : Bozovic-Spasojevic I, de Azambuja E, McCaskill-Stevens W, Dinh P, Cardoso F
Year : 2012
Journal : Cancer Treat Rev
Volume : 38(5)
Pages : 329-339

Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines?

Authors : Burstein HJ, Piccart-Gebhart M, Perez EA, Hortobagyi GN, Wolmark N, Albain KS, Norton L, Winer EP, Hudis CA
Year : 2012
Journal : J. Clin. Oncol.
Volume : 30(18)
Pages : 2179-82

The confusion around neuroendocrine tumors.

Authors : Hendlisz A, Deleporte A
Year : 2012
Journal : Curr Opin Oncol
Volume : 24(4)
Pages : 431-2

Prevention and management of major side effects of targeted agents in breast cancer.

Authors : Metzger Filho O, Saini KS, Azim HA, Awada A
Year : 2012
Journal : Crit Rev Oncol Hematol
Volume : 84(1)
Pages : e79-85

Bone metastasis in breast cancer: The story of RANK-Ligand.

Authors : Azim HA, Kamal NS
Year : 2012
Journal : J Egypt Natl Canc Inst
Volume : 24(3)
Pages : 107-14

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

Authors : Baselga J, Campone M, Piccart-Gebhart M, Burris HA, Rugo HS, Sahmoud T, Noguchi S, Gnant M, Pritchard KI, Lebrun F, Beck JT, Ito Y, Yardley D, Deleu I, Perez A, Bachelot T, Vittori L, Xu Z, Mukhopadhyay P, Lebwohl D, Hortobagyi GN
Year : 2012
Journal : N Engl J Med
Volume : 366(6)
Pages : 520-9

Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.

Authors : Azim HA, Santoro L, Russell-Edu W, Pentheroudakis G, Pavlidis N, Peccatori FA
Year : 2012
Journal : Cancer Treat Rev
Volume : 38(7)
Pages : 834-42

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study.

Authors : Maréchal R, Vos B, Polus M, Delaunoit T, Peeters M, Demetter P, Hendlisz A, Demols A, Franchimont D, Verset G, Van Houtte P, Van de Stadt J, Van Laethem JL
Year : 2012
Journal : Ann Oncol
Volume : 23(6)
Pages : 1525-30

The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer.

Authors : Mouton C, Ronson A, Razavi D, Delhaye F, Kupper N, Paesmans M, Moreau M, Nogaret JM, Hendlisz A, Gidron Y
Year : 2012
Journal : Auton Neurosci
Volume : 166(1-2)
Pages : 96-9

New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel.

Authors : Van Laethem JL, Verslype C, Iovanna JL, Michl P, Conroy T, Louvet C, Hammel P, Mitry E, Ducreux M, Maraculla T, Uhl W, Van Tienhoven G, Bachet JB, Maréchal R, Hendlisz A, Bali M, Demetter P, Ulrich F, Aust D, Luttges J, Peeters M, Mauer M, Roth A, Neoptolemos JP, Lutz M
Year : 2012
Journal : Ann Oncol
Volume : 23(3)
Pages : 570-6

Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement.

Authors : Porta C, Tortora G, Linassier C, Papazisis K, Awada A, Berthold D, Maroto JP, Powles T, De Santis M
Year : 2012
Journal : Med. Oncol.
Volume : 29(3)
Pages : 1896-1907

Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study.

Authors : van Cutsem E, Tejpar S, Vanbeckevoort D, Peeters M, Humblet Y, Gelderblom H, Vermorken JB, Viret F, Glimelius B, Gallerani E, Hendlisz A, Cats A, Moehler M, Sagaert X, Vlassak S, Schlichting M, Ciardiello F
Year : 2012
Journal : J. Clin. Oncol.
Volume : 30(23)
Pages : 2861-8

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

Authors : De Santis M, Bellmunt J, Mead G, Kerst JM, Leahy M, Maroto P, Gil T, Marreaud S, Daugaard G, Skoneczna I, Collette S, Lorent J, de Wit R, Sylvester R
Year : 2012
Journal : J. Clin. Oncol.
Volume : 30(2)
Pages : 191-9

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

Authors : Azim HA, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart-Gebhart M, Sotiriou C, Loi S
Year : 2012
Journal : Clin Cancer Res
Volume : 18(5)
Pages : 1341-51